{
    "id": "0610",
    "question": "A 23-year-old woman, gravida 2, para 1, at 20 weeks of gestation comes to the physician for a routine prenatal exam. Her last pregnancy was unremarkable and she gave birth to a healthy rhesus (RhD) positive girl. Her past medical history is notable for a blood transfusion after a car accident with a complex femur fracture about 3 years ago. Her temperature is 37.2\u00b0C (99\u00b0F), pulse is 92/min, and blood pressure is 138/82 mm Hg. Examination shows that the uterus is at the umbilicus. Ultrasound examination reveals normal fetal heart rate, movement, and anatomy. Routine prenatal labs show the following:\nBlood type A Rh-\nLeukocyte count 11,000/mm3\nHemoglobin 12.5 g/dL\nPlatelet count 345,000/mm3\nSerum\nAnti-D antibody screen Negative\nRubella IgM Negative\nRubella IgG Negative\nVaricella IgM Negative\nVaricella IgG Positive\nSTD panel Negative\nUrine\nProtein Trace\nCulture No growth\nCervical cytology Normal\nWhich of the following is the best next step in management of this patient?\"",
    "options": {
        "A": "Repeat antibody screening at 28 weeks. Administer anti-D immunoglobulin at 28 weeks and after delivery if the newborn is Rh(D) positive.",
        "B": "Repeat antibody screening at 28 weeks and administer anti-D immunoglobulin at 28 weeks. No further management is needed.",
        "C": "No further screening is needed. Administer anti-D immunoglobulin shortly after delivery",
        "D": "No further management is needed\n\""
    },
    "answer": "A",
    "predict": "Here's the step-by-step thinking and the answer in JSON format: ``` { \"step_by_step_thinking\": \"The patient is at 20 weeks of gestation and has a history of a blood transfusion with Rh-negative blood. The patient's past medical history and current lab results show no evidence of Rh incompatibility or other conditions that would require immediate intervention. The rubella IgM and IgG tests are negative, which reduces the risk of congenital rubella syndrome. The varicella IgM is positive, but this is not uncommon in pregnant women and does not necessarily indicate a problem. The STD panel is negative, and the urine culture shows no growth, which suggests no urinary tract infection. The cervical cytology is normal, and the patient's blood type is Rh-negative, which is consistent with her previous pregnancy. Given these results, there is no immediate need for further screening or intervention. However, it is recommended to repeat the antibody screening at 28 weeks to monitor for any potential changes in the patient's antibody status. Additionally, since the patient had a previous blood transfusion, it is recommended to administer anti-D immunoglobulin at 28 weeks and after delivery if the newborn is Rh-positive to prevent sensitization.\", \"answer_choice\": \"B\" } ``` The reasoning behind this answer is as follows: * The patient's past medical history and current lab results show no evidence of Rh incompatibility or other conditions that would require immediate intervention. * The rubella IgM and IgG tests are negative, which reduces the risk of congenital rubella syndrome. * The varicella IgM is positive, but this is not uncommon in pregnant women and does not necessarily indicate a problem. * The STD panel is negative, and the urine culture shows no growth, which suggests no urinary tract infection. * The cervical cytology is normal, and the patient's blood type is Rh-negative, which is consistent with her previous pregnancy. * Given these results, there is no immediate need for further screening or intervention. * However, it is recommended to repeat the antibody screening at 28 weeks to monitor for any potential changes in the patient's antibody status. * Additionally, since the patient had a previous blood transfusion, it is recommended to administer anti-D immunoglobulin at 28 weeks and after delivery if the newborn is Rh-positive to prevent sensitization. Therefore, option B is the best choice, as it involves repeating the antibody screening at 28 weeks and administering anti-D immunoglobulin at 28 weeks, without further management being needed.",
    "snippets": [
        {
            "id": "Obstentrics_Williams_8808",
            "title": "Obstentrics_Williams",
            "content": "Rubella virus may be isolated from the urine, blood, nasopharynx, and cerebrospinal fluid for up to 2 weeks after rash onset. The diagnosis is usually made, however, with serological analysis. In one study, 6 percent of nonimmune women seroconverted to rubella virus during pregnancy (Hutton, 2014). Specific IgM antibody can be detected using enzyme-linked immunoassay for 4 to 5 days after onset of clinical disease, but antibody can persist for up to 6 weeks after appearance of the rash. Importantly, rubella virus reinfection can give rise to transient low levels of IgM. With this, fetal infection can rarely occur, but no adverse fetal efects have been described. Serum IgG antibody titers peak 1 to 2 weeks after rash onset. his rapid antibody response may complicate serodiagnosis unless samples are initially collected within a few days after the onset of the rash. If, for example, the first specimen was obtained 10 days after the rash, detection of IgG antibodies would fail to"
        },
        {
            "id": "Pediatrics_Nelson_1384",
            "title": "Pediatrics_Nelson",
            "content": "Figure 62-1 Differential diagnosis of neonatal anemia. The physician obtains information from the family, maternal and labor and delivery histories, and laboratory tests, including hemoglobin, reticulocyte count, blood type, direct Coombs test, peripheral smear, red blood cell (RBC) indices, and bilirubin concentration. DIC, Disseminated intravascular coagulation; FTA, fluorescent treponemal antibody test; G6PD, glucose-6-phosphate dehydrogenase; HIV, human immunodeficiency virus; KB, Kleihauer-Betke; PCN, penicillin; RPR, rapid plasma reagin tests; TORCH, toxoplasmosis, other, rubella, cytomegalovirus, herpes simplex. (From Ohls RK: Anemia in the neonate. In Christensen RD, editor: Hematologic problems of the neonate, Philadelphia, 2000, Saunders, p 162.) maternal circulation, such as first-trimester abortion, ectopic pregnancy, amniocentesis, manual extraction of the placenta, version (external or internal) procedures, or normal pregnancy."
        },
        {
            "id": "InternalMed_Harrison_15606",
            "title": "InternalMed_Harrison",
            "content": "A susceptible pregnant woman exposed to rubella virus should be tested for IgM antibodies and/or a fourfold rise in IgG antibody titer between acuteand convalescent-phase serum specimens to determine whether she was infected during pregnancy. Pregnant women with evidence of acute infection must be clinically monitored, and gestational age at the time of maternal infection must be determined to assess the possibility of risk to the fetus. Of women infected with rubella virus during the first 11 weeks of gestation, up to 90% deliver an infant with CRS; for maternal infection during the first 20 weeks of pregnancy, the CRS rate is 20%."
        },
        {
            "id": "Obstentrics_Williams_8777",
            "title": "Obstentrics_Williams",
            "content": "Routine prenatal CMV serological screening is currently not recommended by the Society for Maternal-Fetal Medicine (2016). An algorithm for management is shown in Figure 64-2. Pregnant women should be tested for CMV if they present with a mononucleosis-like illness or if congenital infection is suspected based on abnormal sonographic indings. Primary infection is diagnosed using CMV-speciic IgG testing of paired acute and convalescent sera. CMV IgM does not accurately relect timing of seroconversion because IgM antibody levels may be elevated for more than a year (Stagno, 1985). Moreover, CMV IgM may be found with reactivation disease or reinfection with a new strain. Thus, specific CMV IgG avidity testing is valuable Abnormal Maternal CMV Screening CMV IgG: positive CMV IgM: positive CMV-specific IgG and IgM by EIA, IgG avidity by EIA, and CMV-specific IgM by immunoblot CMV IgG: negative CMV IgM: negative CMV IgG: positive IgG avidity index: high"
        },
        {
            "id": "Obstentrics_Williams_1083",
            "title": "Obstentrics_Williams",
            "content": "Recommended routine tests at the first prenatal encounter are listed in Table 9-1. Initial blood tests include a complete blood count, a determination of blood type with h status, and an antibody screen. The Institute of Medicine recommends universal human immunodeiciency virus (HIV) testing, with patient notiication and right of refusal, as a routine part of prenatal care. The CDC (Branson, 2006) as well as the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists (20 16f, 2017) continue to support this practice. If a woman declines testing, this is recorded in the prenatal record. All pregnant women are also screened for hepatitis B virus infection, syphilis, and immunity to rubella at the initial visit. Based on their prospective investigation of 1000 women, Murray and coworkers (2002) concluded that in the absence of hypertension, routine urinalysis beyond the irst prenatal visit was not necessary. A urine culture is recommended by most because"
        },
        {
            "id": "Pediatrics_Nelson_1382",
            "title": "Pediatrics_Nelson",
            "content": "Normal or elevated reticulocyte count (> 5\u221210%) Coombs positive Isoimmunization: Rh (D antigen) ABO, C, c, E, G Duffy, Kell Other minor group Drug-induced (PCN) Coombs negative Blood smear Specific RBC dysmorphology Obtain incubated osmotic fragility test Elliptocytes Poikilocytes Stomatocytes Fragmentation Basophilic stippling Spherocytes Blood cultures, obtain maternal serum for IgG, IgM, HIV, RPR/FTA RBC morphology Hypochromic microcytic RBCs Normal RBC morphology Chronic fetomaternal bleed Chronic twin-to-twin transfusion Alpha-thalassemia trait Gamma-thalassemia Consider acute blood loss due to obstetric complications, external or internal hemorrhage, DIC/sepsis, bleeding dyscrasias Low reticulocyte count (0\u22122%) Obtain bone marrow Obtain hemoglobin electrophoresis, KB stain Obtain specific enzyme assay Diamond-Blackfan Aase syndrome Congenital dyserythropoietic anemias Refractory sideroblastic anemia Transcobalamin II deficiency Orotic aciduria No jaundiceJaundice Other"
        },
        {
            "id": "Pediatrics_Nelson_2143",
            "title": "Pediatrics_Nelson",
            "content": "Routine laboratory findings are nonspecific and generally do not aid in diagnosis. The white blood cell count usually is normal or low, and thrombocytopenia rarely occurs. Diagnosis is confirmed by serologic testing for IgM antibodies (typically positive 5 days after symptom onset) or by a fourfold or greater increase in specific IgG antibodies in paired acute and convalescent sera. CRS cases can have detectable IgM until 3 months of age, and stable or rising IgG titers over the first 7 to 11 months of age. False-positive IgM results can occur. Cases of suspected congenital rubella syndrome and postnatal rubella infection should be reported to the local and state health department. The rash must be differentiated from measles, roseola, enteroviral or adenoviral infection, infectious mononucleosis, toxoplasmosis, scarlet fever, rickettsial disease, Kawasaki disease, serum sickness, and drug rash."
        },
        {
            "id": "First_Aid_Step2_705",
            "title": "First_Aid_Step2",
            "content": "Limb defects have been associated with CVS performed at \u2264 9 weeks. T AB LE 2.1 1 -2. Prenatal Diagnostic Testing Schedule Prenatal visits Weeks 0\u201328: Every four weeks. Weeks 29\u201335: Every two weeks. Weeks 36\u2013birth: Every week. Initial visit 9\u201314 weeks Offer PAPP-A + nuchal transparency + free \u03b2-hCG +/\u2013 CVS. 15\u201320 weeks Offer MSAFP or quad screen (AFP, estriol, \u03b2-hCG, and inhibin A) +/\u2013 amniocentesis. 18\u201320 weeks Ultrasound for full anatomic screen. 24\u201328 weeks One-hour glucose challenge test for gestational diabetes screen. Heme: CBC, Rh factor, type and screen. Infectious disease: UA and culture, rubella antibody titer, HBsAg, RPR/VDRL, cervical gonorrhea and chlamydia, PPD, HIV, Pap smear (to check for dysplasia). If indicated: HbA1c, sickle cell screening. Discuss genetic screening: Tay-Sachs, CF. Recommended at 15\u201320 weeks. Consists of transabdominal aspiration of amniotic fuid using an ultrasound-guided needle and evaluation of fetal cells for genetic studies."
        },
        {
            "id": "InternalMed_Harrison_15604",
            "title": "InternalMed_Harrison",
            "content": "Diagnostic tests used to confirm CRS include serologic assays and virus detection. In an infant with congenital infection, serum IgM antibodies are normally present for up to 6 months but may be detectable for up to 1 year after birth. In some instances, IgM may not be detectable until 1 month of age; thus infants who have symptoms consistent with CRS but who test negative shortly after birth should be retested at 1 month. A rubella serum IgG titer persisting beyond the time expected after passive transfer of maternal IgG antibody (i.e., a rubella titer that does not decline at the expected rate of a twofold dilution per month) is another serologic criterion used to confirm CRS."
        },
        {
            "id": "Pharmacology_Katzung_6153",
            "title": "Pharmacology_Katzung",
            "content": "When the mother has been treated in this fashion, Rh hemolytic disease of the newborn has not been observed in subsequent pregnancies. For this prophylactic treatment to be successful, the mother must be Rho(D)-negative and Du-negative and must not already be immunized to the Rho(D) factor. Treatment is also often advised for Rh-negative mothers antepartum at 26\u201328 weeks\u2019 gestation who have had miscarriages, ectopic pregnancies, or abortions, when the blood type of the fetus is unknown. Note: Rho(D) immune globulin is administered to the mother and must not be given to the infant. The usual dose of Rho(D) immune globulin is 2 mL intramuscularly, containing approximately 300 mcg anti-Rho(D) IgG. Adverse reactions are infrequent and consist of local discomfort at the injection site or, rarely, a slight temperature elevation."
        },
        {
            "id": "Gynecology_Novak_6279",
            "title": "Gynecology_Novak",
            "content": "For a patient to be diagnosed with antiphospholipid antibody syndrome, one or more clinical and one or more laboratory criteria must be present: 1. One or more confirmed episode of vascular thrombosis of any type: Venous Arterial Small vessel 2. Pregnancy complications: of gestation with exclusion of maternal anatomic and hormonal abnormalities and exclusion of paternal and maternal chromosomal abnormalities One or more unexplained deaths of a morphologically normal fetus at or beyond 10 weeks of gestation (normal fetal morphology documented by ultra sound or direct examination of the fetus) One or more premature births of a morphologically normal neonate at or before 34 weeks of gestation secondary to severe preeclampsia or placental insufficiency Testing must be positive on two or more occasions with evaluations 12 or more weeks apart: 1. Positive plasma levels of anticardiolipin antibodies of the IgG or IgM isotype at medium to high levels 2."
        },
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "Pharmacology_Katzung_5664",
            "title": "Pharmacology_Katzung",
            "content": "Philip J. Rosenthal, MD A 5-year-old American girl presents with a 1-week history of intermittent chills, fever, and sweats. She had returned home 2 weeks earlier after leaving the USA for the first time to spend 3 weeks with her grandparents in Nigeria. She received all standard childhood immunizations, but no additional treat-ment before travel, since her parents have returned to their native Nigeria frequently without medical consequences. Three days ago, the child was seen in an outpatient clinic and diagnosed with a viral syndrome. Examination reveals a lethargic child, with a temperature of 39.8\u00b0C (103.6\u00b0F) and splenomegaly. She has no skin rash or lymphadenopathy. Ini-tial laboratory studies are remarkable for hematocrit 29.8%, platelets 45,000/mm3, creatinine 2.5 mg/dL (220 \u03bcmol/L), and mildly elevated bilirubin and transaminases. A blood smear shows ring forms of Plasmodium falciparum at 1.5% parasit-emia. What treatment should be started?"
        },
        {
            "id": "Pharmacology_Katzung_5336",
            "title": "Pharmacology_Katzung",
            "content": "Sharon Safrin, MD A 35-year-old white woman who recently tested seropositive for both HIV and hepatitis B virus surface antigen is referred for evaluation. She is feeling well overall but reports a 25-pack-year smoking history. She drinks 3\u20134 beers per week and has no known medication allergies. She has a history of heroin use and is currently receiving methadone. Physical examination reveals normal vital signs and no abnormalities. White blood cell count is 5800 cells/mm3 with a normal differential, hemoglobin is 11.8 g/dL, all liver tests are within normal limits, CD4 cell count is 278 cells/mm3, and viral load (HIV RNA) is 110,000 copies/mL. What other laboratory tests should be ordered? Which antiretroviral medica-tions would you begin?"
        },
        {
            "id": "InternalMed_Harrison_605",
            "title": "InternalMed_Harrison",
            "content": "Rubella (See also Chap. 230e) Rubella virus is a known teratogen; first-trimester rubella carries a high risk of fetal anomalies, though the risk significantly decreases later in pregnancy. Congenital rubella may be diagnosed by percutaneous umbilical-blood sampling with the detection of IgM antibodies in fetal blood. All pregnant women and all women of childbearing age should be tested for their immune status to rubella. All nonpregnant women who are not immune to rubella should be vaccinated. The incidence of congenital rubella in the United States is extremely low."
        },
        {
            "id": "Pharmacology_Katzung_5171",
            "title": "Pharmacology_Katzung",
            "content": "A 59-year-old woman presents to an urgent care clinic with a 4-day history of frequent and painful urination. She has had fevers, chills, and flank pain for the past 2 days. Her physician advised her to come immediately to the clinic for evaluation. In the clinic she is febrile (38.5\u00b0C [101.3\u00b0F]) but otherwise stable and states she is not experiencing any nausea or vomiting. Her urine dipstick test is positive for leukocyte esterase. Urinalysis and urine culture are ordered. Her past medical history is significant for three urinary tract infections in the past year. Each episode was uncom-plicated, treated with trimethoprim-sulfamethoxazole, and promptly resolved. She also has osteoporosis for which she takes a daily calcium supplement. The decision is made to treat her with oral antibiotics for a complicated urinary tract infection with close follow-up. Given her history, what would be a reasonable empiric antibiotic choice? Depending on the antibiotic choice are there potential drug"
        },
        {
            "id": "Pharmacology_Katzung_5286",
            "title": "Pharmacology_Katzung",
            "content": "Harry W. Lampiris, MD, & Daniel S. Maddix, Pharm D The patient is a 37-year-old African-American man who lives in San Jose, California. He was recently incarcerated near Bakersfield, California and returned to Oakland about 3 months ago. He is currently experiencing one month of severe headache and double vision. He has a temperature of 38.6\u00b0C (101.5\u00b0F) and the physical exam reveals nuchal rigidity and right-sided sixth cranial nerve palsy. MRI of his brain is normal, and lumbar puncture reveals 330 WBC with 20% eosinophils, protein 75, and glucose 20. HIV test is negative, TB skin test is negative, CSF cryptococcal antigen is negative, and CSF gram stain is negative. Patient receives empiric therapy for bacterial meningitis with van-comycin and ceftriaxone, and is unimproved after 72 hours of treatment. After 3 days a white mold is identified growing from his CSF culture. What medical therapy would be most appropriate now?"
        },
        {
            "id": "Pharmacology_Katzung_3614",
            "title": "Pharmacology_Katzung",
            "content": "A 25-year-old woman who has been on a strict vegan diet for the past 2 years presents with increasing numbness and paresthesias in her extremities, generalized weakness, a sore tongue, and gastrointestinal discomfort. Physical examina-tion reveals a pale woman with diminished vibration sen-sation, diminished spinal reflexes, and extensor plantar reflexes (Babinski sign). Examination of her oral cavity reveals atrophic glossitis, in which the tongue appears deep red in color and abnormally smooth and shiny due to atro-phy of the lingual papillae. Laboratory testing reveals a mac-rocytic anemia based on a hematocrit of 30% (normal for women, 37\u201348%), a hemoglobin concentration of 9.4 g/dL, an erythrocyte mean cell volume (MCV) of 123 fL (nor-mal, 84\u201399 fL), an erythrocyte mean cell hemoglobin con-centration (MCHC) of 34% (normal, 31\u201336%), and a low reticulocyte count. Further laboratory testing reveals a normal serum folate concentration and a serum vitamin B12 (cobalamin) concentration"
        },
        {
            "id": "Pharmacology_Katzung_6809",
            "title": "Pharmacology_Katzung",
            "content": "A 21-year-old woman comes with her parents to discuss therapeutic options for her Crohn\u2019s disease. She was diag-nosed with Crohn\u2019s disease 2 years ago, and it involves her terminal ileum and proximal colon, as confirmed by colonoscopy and small bowel radiography. She was initially treated with mesalamine and budesonide with good response, but over the last 2 months, she has had a relapse of her symptoms. She is experiencing fatigue, cramping, abdominal pains, and nonbloody diarrhea up to 10 times daily, and she has had a 15-lb weight loss. She has no other significant medical or surgical his-tory. Her current medications are mesalamine 2.4 g/d and budesonide 9 mg/d. She appears thin and tired. Abdominal examination reveals tenderness without guarding in the right lower quadrant; no masses are palpable. On perianal examination, there is no tenderness, fissure, or fistula. Her laboratory data are notable for anemia and elevated C-reactive protein. What are the options for immediate"
        },
        {
            "id": "Pharmacology_Katzung_5050",
            "title": "Pharmacology_Katzung",
            "content": "Camille E. Beauduy, PharmD, & Lisa G. Winston, MD motion tenderness is present. A first-catch urine specimen is obtained for chlamydia and gonorrhea nucleic acid amplifi-cation testing. A urine pregnancy test is also ordered as the patient reports she \u201cmissed her last period.\u201d Pending these results, the decision is made to treat her presumptively for chlamydial cervicitis. What are two potential treatment options for her possible chlamydial infection? How does her potential pregnancy affect the treatment decision? A 22-year-old woman presents to her college medical clinic complaining of a 2-week history of vaginal discharge. She denies any fever or abdominal pain but does report vaginal bleeding after sexual intercourse. When questioned about her sexual activity, she reports having vaginal intercourse, at times unprotected, with two men in the last 6 months. A pelvic examination is performed and is positive for muco-purulent discharge from the endocervical canal. No cervical"
        },
        {
            "id": "InternalMed_Harrison_15597",
            "title": "InternalMed_Harrison",
            "content": "Congenital Rubella Syndrome The most serious consequence of rubella virus infection can develop when a woman becomes infected during pregnancy, particularly during the first trimester. The resulting complications may include miscarriage, fetal death, premature delivery, or live birth with congenital defects. Infants infected with rubella virus in utero may have myriad physical defects (Table 230e-1), which most commonly relate to the eyes, ears, and heart. This constellation of severe birth defects is known as congenital rubella syndrome. In addition to permanent manifestations, there are a host of transient physical manifestations, including thrombocytopenia with purpura/petechiae (e.g., dermal erythropoiesis, \u201cblueberry muffin syndrome\u201d). Some infants may be born with congenital rubella virus infection but have no apparent signs or symptoms of CRS and are referred to as \u201cinfants with congenital rubella infection only.\u201d"
        },
        {
            "id": "Obstentrics_Williams_2005",
            "title": "Obstentrics_Williams",
            "content": "At the first prenatal visit, a blood type and antibody screen are routinely assessed, and unbound antibodies in maternal serum are detected by the indirect Coombs test (Chap. 9, p. 160). When the result is positive, the specific antibodies are identified, their immunoglobulin subtype is determined as either immunoglobulin G (IgG) or M (IgM) , and the titer is quantiied. Only IgG antibodies are a concern because IgM antibodies do not cross the placenta. Selected antibodies and their potential to cause fetal hemolytic anemia are listed in Table he critical titer is the level at which significant fetal anemia could potentially develop. This may be diferent for each antibody, is determined individually by each laboratory, and usually ranges between 1:8 and 1 :32. If the critical titer for anti-D antibodies is 1: 16, a titer : 1: 16 indicates the possibility of severe hemolytic disease. An important exception is Kell sensitization, which is discussed on page 302."
        },
        {
            "id": "Pediatrics_Nelson_1392",
            "title": "Pediatrics_Nelson",
            "content": "Prevention of sensitization of the mother carrying an Rh-positive fetus is possible by treating the mother during gestation (>28 weeks\u2019 gestational age) and within 72 hours after birth with anti-Rh-positive immune globulin (RhoGAM). The dose of RhoGAM (300 \u03bcg) is based on the ability of this amount of anti-Rh-positive antibody to bind all the possible fetal Rh-positive erythrocytes entering the maternal circulation during the fetal-to-maternal transfusion at birth (approximately 30 mL). RhoGAM may bind Rh-positive fetal erythrocytes or interfere with maternal anti-Rh-positive antibody production by another, unknown mechanism. RhoGAM is effective only in preventing sensitization to the D antigen. Other blood group antigens that can cause immune hydrops and erythroblastosis include Rh C, E, Kell, and Duffy. Anti-Kell alloimmunity produces lower amniotic bilirubin levels and a lower reticulocyte count because, in addition to hemolysis, it inhibits erythropoiesis."
        },
        {
            "id": "Anatomy_Gray_1249",
            "title": "Anatomy_Gray",
            "content": "This patient had no symptoms attributable to the pelvic kidney and she was discharged. A 19-year-old woman presented to the emergency department with a 36-hour history of lower abdominal pain that was sharp and initially intermittent, later becoming constant and severe. The patient also reported feeling nauseated and vomited once in the ER. She did not have diarrhea and had opened her bowels normally 8 hours before admission. She had no symptoms of dysuria. She was afebrile, slightly tachycardic at 95/min, and had a normal blood pressure. Blood results showed mild leukocytosis of 11.6 x 109/L and normal renal and liver function tests. She reported being sexually active with a long-term partner. She was never pregnant, and the urine pregnancy test on admission was negative."
        },
        {
            "id": "Pharmacology_Katzung_1130",
            "title": "Pharmacology_Katzung",
            "content": "Irbesartan Generic,Avapro Treatment of Angina Pectoris Bertram G. Katzung, MD, PhD* A 56-year-old woman presents in the office with a history of recent-onset chest discomfort when jogging or swimming vigorously. The pain is dull but poorly localized; it disap-pears after 5\u201310 minutes of rest. She has never smoked but has a history of hyperlipidemia (total cholesterol level of 245 mg/dL and low-density lipoprotein [LDL] of 160 mg/dL recorded 1 year ago) and admits that she has not been fol-lowing the recommended diet. Her father survived a \u201cheart attack\u201d at age 55, and an uncle died of some cardiac disease at age 60. On physical examination, the patient\u2019s blood pressure is 145/90 mm Hg, and her heart rate is 80 bpm. She is in no acute distress, and there are no other significant physical findings; an electrocardiogram is normal except for slight left ventricular hypertrophy. Assuming that a diagno-sis of stable effort angina is correct, what medical treatment should be implemented?"
        },
        {
            "id": "Pharmacology_Katzung_3731",
            "title": "Pharmacology_Katzung",
            "content": "James L. Zehnder, MD and edema and is tender to touch. Oxygen saturation by fingertip pulse oximeter while breathing room air is 87% (normal > 90%). Ultrasound reveals a deep vein thrombosis in the left lower extremity; chest computed tomography scan confirms the presence of pulmonary emboli. Laboratory blood tests indicate elevated d-dimer levels. What therapy is indicated acutely? What are the long-term therapy options? How long should she be treated? Should this indi-vidual use oral contraceptives? A 25-year-old woman presents to the emergency depart-ment complaining of acute onset of shortness of breath and pleuritic pain. She had been in her usual state of health until 2 days prior when she noted that her left leg was swollen and red. Her only medication was oral contraceptives. Family history was significant for a history of \u201cblood clots\u201d in mul-tiple members of the maternal side of her family. Physical examination demonstrates an anxious woman with stable vital signs. The left"
        },
        {
            "id": "Pharmacology_Katzung_5601",
            "title": "Pharmacology_Katzung",
            "content": "A 65-year-old man undergoes cystoscopy because of the presence of microscopic hematuria in order to rule out urologic malignancy. The patient has mild dysuria and pyuria and empirically receives oral therapy with cip-rofloxacin for presumed urinary tract infection prior to the procedure and tolerates the procedure well. Approxi-mately 48 hours after the procedure, the patient presents to the emergency department with confusion, dysuria and chills. Physical exam reveals a blood pressure of 90/50, pulse of 120, temperature of 38.5\u00b0 C and respira-tory rate of 24. The patient is disoriented but the physical exam is otherwise unremarkable. Laboratory test shows WBC 24,000/mm3 and elevated serum lactate; urinalysis shows 300 WBC per high power field and 4+ bacteria. What possible organisms are likely to be responsible for the patient\u2019s symptoms? At this point, what antibiotic(s) would you choose for initial therapy of this potentially life-threatening infection?"
        },
        {
            "id": "Pharmacology_Katzung_7061",
            "title": "Pharmacology_Katzung",
            "content": "A 53-year-old woman with a history of knee osteoarthritis, high cholesterol, type 2 diabetes, and hypertension presents with new onset of hot flashes and a question about a dietary supplement. She is obese (body mass index [BMI] 33), does not exercise, and spends a good portion of her work day in a seated position. She eats a low-sugar diet and regularly eats packaged frozen meals for dinner because she doesn\u2019t have time to cook regularly. Her most recent laboratory values include a low-density lipoprotein (LDL) cholesterol that is above goal at 160 mg/dL (goal < 100 mg/dL) and a hemo-globin A1c that is well controlled at 6%. Her blood pressure is high at 160/100 mm Hg. Her prescription medications include simvastatin, metformin, and benazepril. She also takes over-the-counter ibuprofen for occasional knee pain and a multivitamin supplement once daily. She has heard good things about natural products and asks you if taking a garlic supplement daily could help to bring her blood"
        },
        {
            "id": "Immunology_Janeway_4329",
            "title": "Immunology_Janeway",
            "content": "Coombs tests use anti-immunoglobulin antibodies to detect the antibodies that cause hemolytic disease of the newborn, or erythroblastosis fetalis. Anti-immunoglobulin antibodies were first developed by Robin Coombs, and the test for this disease is still called the Coombs test. Hemolytic disease of the newborn occurs when a mother makes IgG antibodies specific for the rhesus or Rh bloodgroup antigen expressed on the red blood cells of her fetus. Rh-negative mothers make these antibodies when they are exposed at delivery to Rh-positive fetal red blood cells bearing the paternally inherited Rh antigen. During subsequent pregnancies, these antibodies are transported across the placenta to the fetus. This normal process is generally beneficial, as it protects newborn infants against infection. However, IgG anti-Rh antibodies coat the fetal red blood cells, which are then destroyed by phagocytic cells in the liver, causing a hemolytic anemia in the fetus and newborn infant."
        },
        {
            "id": "Obstentrics_Williams_2044",
            "title": "Obstentrics_Williams",
            "content": "The dosage of anti-D immune globulin is calculated from the estimated volume of the fetal-to-maternal hemorrhage, as described on page 307. One 300-\ufffdg dose is given for each 15 mL of fetal red cells or 30 mL of fetal whole blood to be neutralized. If using an intramuscular preparation of anti-D immune globulin, no more than five doses may be given in a 24-hour period. If using an intravenous preparation, two ampules-totaling 600 \ufffdg-may be given every 8 hours. To determine if the administered dose was adequate, the indirect Coombs test may be performed. A positive result indicates that there is excess anti-D immunoglobulin in maternal serum, thus demonstrating that the dose was suicient. Alternatively, a rosette test may be performed to assess whether circulating fetal cells remain."
        },
        {
            "id": "Pharmacology_Katzung_6087",
            "title": "Pharmacology_Katzung",
            "content": "IgG immunoglobulins. One example of this type of hypersensitivity is a blood transfusion reaction that can occur if blood is not cross-matched properly. Preformed antibodies bind to red blood cell membrane antigens that activate the complement cascade, generating a membrane attack complex that lyses the transfused red blood cells. In hemolytic disease of the newborn, anti-Rh IgG antibodies produced by an Rh-negative mother cross the placenta, bind to red blood cells of an Rh-positive fetus, and damage them. The disease is prevented in subsequent pregnancies by the administration of anti-Rh antibodies to the mother 24\u201348 hours after delivery (see Immunosuppressive Antibodies, below). Type II hypersensitivity can also be drug-induced and may occur during the administration of penicillin (for example) to allergic patients. In these patients, penicillin binds to red blood cells or other host Naive B cell +IL-4,-5 T helper cell"
        },
        {
            "id": "InternalMed_Harrison_13716",
            "title": "InternalMed_Harrison",
            "content": "the patient is at high risk of reinfection, serologic testing should be repeated in the third trimester and at delivery. Neonatal congenital syphilis must be differentiated from other generalized congenital infections, including rubella, cytomegalovirus or herpes simplex virus infection, and toxoplasmosis, as well as from erythroblastosis fetalis."
        }
    ],
    "scores": [
        0.02670312723493888,
        0.026657991131675343,
        0.025065487829451345,
        0.024835292022792024,
        0.024173348320219806,
        0.023890387639748666,
        0.023821608089342645,
        0.02363163382643784,
        0.021987457753839347,
        0.020975625976789813,
        0.02079328223437279,
        0.019704911667637354,
        0.019704911667637354,
        0.019049346879535557,
        0.01899189918991899,
        0.018532818532818532,
        0.018042071197411004,
        0.017998385794995964,
        0.017946241751166908,
        0.017940466613032984,
        0.017862838915470493,
        0.017837323608688758,
        0.017831591754219785,
        0.017786561264822136,
        0.017158294392523366,
        0.01646787747357007,
        0.01637840670859539,
        0.01595677050222505,
        0.01579520697167756,
        0.015746109246261825,
        0.015512265512265512,
        0.015343915343915344
    ]
}